Assertio Holdings, Inc. ("Assertio" or the "Company") today announced that results of a clinical trial investigating a novel ...

Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates -- SHANGHAI ...

Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, ...

World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

According to MarketsandMarketstm, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion by 2031, at a CAGR of 35.2%. Browse 250 market data ...

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

This announcement broadens LifeMD’s long-standing collaboration with Novo Nordisk. As part of the relationship, LifeMD is featured on the NovoCare ® and Wegovy ® websites as a trusted telehealth ...

Shifting gears, it turns out that 2025 was a slightly off year for drug approvals by the US Food and Drug Administration. A ...